Pancreatic Cancer

Unfortunately, most pancreatic cancer cases are not found until the disease has reached stage IV.
Pancreatic cancer is called a silent killer because it often grows or spreads undetected. And like many cancers, it presents few warning signs. It’s critically important to educate patients about the options and the importance of early detection. 
On January 29, the Food and Drug Administration approved a lutetium Lu 177 dotatate (Lutathera®), a targeted radiation drug, for the treatment of gastroenteropancreatic neuroendocrine tumors.
Pancreatic cysts are water or mucus filled structures in the pancreas, similar to cysts that appear in other parts of the body. The most common cause of benign (non-cancerous) cysts is pancreatitis, an inflammation of the pancreas.
More than two years ago, when Dr. Bain told me I had pancreatic cancer, my first thought was that nothing can take my 81 years away from me. I’ve had a long, happy life and know what it’s like to overcome hardships and learn important lessons.

Pathologists are key partners of the medical team whose investigations and findings are essential to successful surgical and treatment plans for cancer patients.

There are many advantages to seeking treatment for pancreatic cancer at a National Cancer Institute-designated cancer center, where doctors specialize and are experienced in treating the disease. Pancreatic cancer specialists often take a coordinated approach to treatment, providing a team of medical professionals to develop a personalized care plan for each patient.

When diagnosing or treating cancer, a less-invasive procedure often leads to better outcomes and fewer risks.

Pancreatic cancer is one of the deadliest diseases in the world and the fourth leading cause of cancer death in the United States. A major contributing factor for pancreatic cancer’s high death rate is a lack of effective early detection or screening tests.

Although rare, about 38,000 Americans die from pancreatic cancer each year, making it the fourth deadliest type of cancer in the United States.

Pancreatic cancer research, compared to other diseases, has lagged for decades. It is only recently that research has given us some options for treating these cancers.